Update on Kleefstra Syndrome

Kleefstra syndrome is characterized by the core phenotype of developmental delay/intellectual disability, (childhood) hypotonia and distinct facial features. The syndrome can be either caused by a microdeletion in chromosomal region 9q34.3 or by a mutation in the euchromatin histone methyltransferase 1 (EHMT1) gene. Since the early 1990s, 85 patients have been described, of which the majority had a 9q34.3 microdeletion (>85%). So far, no clear genotype-phenotype correlation could be observed by studying the clinical and molecular features of both 9q34.3 microdeletion patients and patients with an intragenic EHMT1 mutation. Thus, to further expand the genotypic and phenotypic knowledge about the syndrome, we here report 29 newly diagnosed patients, including 16 patients with a 9q34.3 microdeletion and 13 patients with an EHMT1 mutation, and review previous literature. The present findings are comparable to previous reports. In addition to our former findings and recommendations, we suggest cardiac screening during follow-up, because of the possible occurrence of cardiac arrhythmias. In addition, clinicians and caretakers should be aware of the regressive behavioral phenotype that might develop at adolescent/adult age and seems to have no clear neurological substrate, but is rather a so far unexplained neuropsychiatric feature.

[1]  B. Hirsch,et al.  Infant with multiple congenital anomalies and deletion (9)(q34.3). , 1994, American journal of medical genetics.

[2]  E. Maltby,et al.  A report of a child with a deletion (9)(q34.3): a recognisable phenotype? , 1997, Journal of medical genetics.

[3]  Dong Kwan Kim,et al.  Altered Nociceptive Response in Mice Deficient in the α1B Subunit of the Voltage-Dependent Calcium Channel , 2001, Molecular and Cellular Neuroscience.

[4]  David M. Livingston,et al.  A Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive Genes in G0 Cells , 2002, Science.

[5]  C. Greenberg,et al.  Cryptic chromosome rearrangements detected by subtelomere assay in patients with mental retardation and dysmorphic features , 2002, Clinical genetics.

[6]  A. Munnich,et al.  Cryptic terminal deletion of chromosome 9q34: a novel cause of syndromic obesity in childhood? , 2003, Journal of medical genetics.

[7]  E. Zackai,et al.  Subtelomeric deletions of chromosome 9q: A novel microdeletion syndrome , 2004, American journal of medical genetics. Part A.

[8]  D. Weaver,et al.  Clinical and cytogenetic manifestations of subtelomeric aberrations: Report of six cases. , 2004, Birth defects research. Part A, Clinical and molecular teratology.

[9]  N. Niikawa,et al.  A 1-Mb critical region in six patients with 9q34.3 terminal deletion syndrome , 2004, Journal of Human Genetics.

[10]  N. Niikawa,et al.  9q34.3 deletion syndrome in three unrelated children , 2004, American journal of medical genetics. Part A.

[11]  P. Stankiewicz,et al.  Deletion 9q34.3 syndrome: genotype-phenotype correlations and an extended deletion in a patient with features of Opitz C trigonocephaly , 2005, Journal of Medical Genetics.

[12]  B. D. de Vries,et al.  Disruption of the gene Euchromatin Histone Methyl Transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome , 2005, Journal of Medical Genetics.

[13]  D. Srivastava,et al.  Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.

[14]  D. Sillence,et al.  Three patients with terminal deletions within the subtelomeric region of chromosome 9q , 2005, American journal of medical genetics. Part A.

[15]  N. de Leeuw,et al.  Interstitial 2.2 Mb deletion at 9q34 in a patient with mental retardation but without classical features of the 9q subtelomeric deletion syndrome , 2006, American journal of medical genetics. Part A.

[16]  Alex Magee,et al.  Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome. , 2006, American journal of human genetics.

[17]  T. Kleefstra,et al.  The chromosome 9q subtelomere deletion syndrome , 2007, American journal of medical genetics. Part C, Seminars in medical genetics.

[18]  A. C. Chinault,et al.  Molecular mechanisms for subtelomeric rearrangements associated with the 9q34.3 microdeletion syndrome. , 2009, Human molecular genetics.

[19]  R. Pfundt,et al.  Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype , 2009, Journal of Medical Genetics.

[20]  W. Verhoeven,et al.  Behavioral phenotype in the 9q subtelomeric deletion syndrome: A report about two adult patients , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[21]  T. Kleefstra,et al.  Kleefstra syndrome in three adult patients: Further delineation of the behavioral and neurological phenotype shows aspects of a neurodegenerative course , 2011, American journal of medical genetics. Part A.

[22]  A. Hoischen,et al.  Familial Kleefstra syndrome due to maternal somatic mosaicism for interstitial 9q34.3 microdeletions , 2011, Clinical genetics.

[23]  M. Nelen,et al.  Characterization of a novel transcript of the EHMT1 gene reveals important diagnostic implications for Kleefstra syndrome , 2011, Human Mutation.

[24]  Annette Schenck,et al.  Epigenetic Regulation of Learning and Memory by Drosophila EHMT/G9a , 2011, PLoS biology.

[25]  Hans van Bokhoven,et al.  Genetic and epigenetic networks in intellectual disabilities. , 2011, Annual review of genetics.